ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement Yahoo Finance
TSXV: EPI) (“ESSA” or the “Company”), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, is pleased to …